OBJECTIVE: To determine whether overexpression of CYP17 or CYP11A messenger (m)RNA in theca cells from polycystic ovaries is related to polymorphic regions in the gene promoters that may increase transcription. DESIGN: Case-control study. SETTING: Research institute. PATIENT(S): Fifty-one women with PCOS and 280 regularly cycling controls underwent genotyping. Thecal cells were obtained from 23 women with PCOS and 51 controls. MAIN OUTCOME MEASURE(S): Ovarian tissue was obtained from women with PCOS undergoing wedge resection for treatment of their infertility and from controls undergoing ovariectomy for indications unrelated to the study. Expression of mRNA in theca cells was measured by using competitive reverse transcriptase polymerase chain reaction. Genotype analysis for polymorphisms in the CYP11A and CYP17 promoters was performed by using polymerase chain reaction. RESULT(S): Although expression of CYP11A and CYP17 mRNA was higher in women with PCOS, no significant dose effects of CYP11A or CYP17 alleles were observed with respect to serum testosterone; follicular fluid androstenedione, estradiol, and androstenedione-to-estradiol ratio; or CYP11A or CYP17 mRNA expression. CONCLUSION(S): Overexpression of CYP17 and CYP11A mRNA in theca cells from polycystic ovaries is explained by polymorphic differences in the gene promoters.
OBJECTIVE: To determine whether overexpression of CYP17 or CYP11A messenger (m)RNA in theca cells from polycystic ovaries is related to polymorphic regions in the gene promoters that may increase transcription. DESIGN: Case-control study. SETTING: Research institute. PATIENT(S): Fifty-one women with PCOS and 280 regularly cycling controls underwent genotyping. Thecal cells were obtained from 23 women with PCOS and 51 controls. MAIN OUTCOME MEASURE(S): Ovarian tissue was obtained from women with PCOS undergoing wedge resection for treatment of their infertility and from controls undergoing ovariectomy for indications unrelated to the study. Expression of mRNA in theca cells was measured by using competitive reverse transcriptase polymerase chain reaction. Genotype analysis for polymorphisms in the CYP11A and CYP17 promoters was performed by using polymerase chain reaction. RESULT(S): Although expression of CYP11A and CYP17 mRNA was higher in women with PCOS, no significant dose effects of CYP11A or CYP17 alleles were observed with respect to serum testosterone; follicular fluid androstenedione, estradiol, and androstenedione-to-estradiol ratio; or CYP11A or CYP17 mRNA expression. CONCLUSION(S): Overexpression of CYP17 and CYP11A mRNA in theca cells from polycystic ovaries is explained by polymorphic differences in the gene promoters.
Authors: K Ranjith Reddy; M L N Deepika; K Supriya; K Prasanna Latha; S S Lakshmana Rao; V Usha Rani; P Jahan Journal: J Assist Reprod Genet Date: 2014-05-04 Impact factor: 3.412
Authors: Sara H Olson; Irene Orlow; Sharon Bayuga; Camelia Sima; Elisa V Bandera; Katherine Pulick; Shameka Faulkner; Diana Tommasi; Daniel Egan; Pampa Roy; Homer Wilcox; Ali Asya; Ippolito Modica; Haider Asad; Robert Soslow; Ann G Zauber Journal: Cancer Causes Control Date: 2008-04-25 Impact factor: 2.506
Authors: Jennifer H Lin; JoAnn E Manson; Peter Kraft; Barbara B Cochrane; Marc J Gunter; Rowan T Chlebowski; Shumin M Zhang Journal: BMC Med Genet Date: 2011-05-31 Impact factor: 2.103
Authors: Kristjana Einarsdóttir; Tove Rylander-Rudqvist; Keith Humphreys; Susanne Ahlberg; Gudrun Jonasdottir; Elisabete Weiderpass; Kee Seng Chia; Magnus Ingelman-Sundberg; Ingemar Persson; Jianjun Liu; Per Hall; Sara Wedrén Journal: Breast Cancer Res Date: 2005-09-14 Impact factor: 6.466
Authors: Jessica K Wickenheisser; Jessica M Biegler; Velen L Nelson-Degrave; Richard S Legro; Jerome F Strauss; Jan M McAllister Journal: PLoS One Date: 2012-11-14 Impact factor: 3.240